Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke S Howard

Showing results (61-70 of 111) with videos related to

Pageof 12
Sort By:
Circulation|June 4, 2008
Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertensionGerhard-Paul Diller, Sven van Eijl, Darlington O Okonko, et al.
Pulmonary Circulation|December 6, 2021
Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacyMartin R Wilkins, Mikel A Mckie, Martin Law, et al.
Communications Biology|November 7, 2022
An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axisAlexander J Ainscough, Timothy J Smith, Maike Haensel, et al.
Ebiomedicine|June 29, 2021
A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approachNiamh Errington, James Iremonger, Josephine A Pickworth, et al.
European Heart Journal Open|January 15, 2026
GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profilingChinthaka B Samaranayake, Yen-Cheng Chen, Min Fang, et al.
Pulmonary Circulation|November 18, 2021
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertensionRobert P Frantz, Raymond L Benza, Richard N Channick, et al.
Circulation. Genomic and Precision Medicine|April 18, 2025
Diagnostic MicroRNA Signatures to Support Classification of Pulmonary HypertensionNiamh Errington, Li Zhou, Christopher J Rhodes, et al.
Frontiers in Medicine|December 19, 2022
Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challengesRudolf K F Oliveira, Peter S Nyasulu, Adeel Ahmed Iqbal, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Identification of drug candidates for rescue of SOX17 gene targets in pulmonary arterial hypertensionEleni Vasilaki, Bedia Akosman, Shanshan Song, et al.
Circulation|April 25, 2023
Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial HypertensionChristophe Guignabert, Laurent Savale, Athénaïs Boucly, et al.
Pageof 12

Showing results (61-70 of 111) with videos related to

Sort By:
Pageof 12
Circulation|June 4, 2008
Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertensionGerhard-Paul Diller, Sven van Eijl, Darlington O Okonko, et al.
Pulmonary Circulation|December 6, 2021
Positioning imatinib for pulmonary arterial hypertension: A phase I/II design comprising dose finding and single-arm efficacyMartin R Wilkins, Mikel A Mckie, Martin Law, et al.
Communications Biology|November 7, 2022
An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axisAlexander J Ainscough, Timothy J Smith, Maike Haensel, et al.
Ebiomedicine|June 29, 2021
A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approachNiamh Errington, James Iremonger, Josephine A Pickworth, et al.
European Heart Journal Open|January 15, 2026
GLP-1 agonist, semaglutide use in acute pulmonary embolism recovery: a four-week proof-of-concept study including proteomic profilingChinthaka B Samaranayake, Yen-Cheng Chen, Min Fang, et al.
Pulmonary Circulation|November 18, 2021
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertensionRobert P Frantz, Raymond L Benza, Richard N Channick, et al.
Circulation. Genomic and Precision Medicine|April 18, 2025
Diagnostic MicroRNA Signatures to Support Classification of Pulmonary HypertensionNiamh Errington, Li Zhou, Christopher J Rhodes, et al.
Frontiers in Medicine|December 19, 2022
Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challengesRudolf K F Oliveira, Peter S Nyasulu, Adeel Ahmed Iqbal, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Identification of drug candidates for rescue of SOX17 gene targets in pulmonary arterial hypertensionEleni Vasilaki, Bedia Akosman, Shanshan Song, et al.
Circulation|April 25, 2023
Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial HypertensionChristophe Guignabert, Laurent Savale, Athénaïs Boucly, et al.
Pageof 12